Skip to main content
. 2021 Mar 28;13(7):1551. doi: 10.3390/cancers13071551

Figure 5.

Figure 5

ADC and T2 Contrast ratio (CR) between lung cancers and BPNMs. The ADC (1.24 ± 0.29 × 10−3 mm2/s) of lung cancers was significantly lower than that (1.69 ± 0.58 × 10−3 mm2/s) of BPNMs (p < 0.0001). T2 CR was the ratio of T2 signal intensity of the pulmonary nodule divided by T2 signal intensity of a rhomboid muscle. The T2 CR (2.01 ± 1.02) of lung cancers was significantly lower than that (2.74 ± 1.02) of BPNMs (p < 0.0001).